Clinical Trial Update: Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lymphocyte depletion and stem cell transplantation for severe systemic lupus erythematosus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Lymphocyte depletion and stem cell transplantation (investigational regimen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2014-06-10